Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference53 articles.
1. Ali, A.A., R.S. Weinstein, S.A. Stewart, A.M. Parfitt, S.C. Manolagas, and R.L. Jilka. 2005. Rosiglitazone causes bone loss in mice by suppressing osteoblast and bone formation. Endocrinology 146: 1226–1235.
2. Aliquier, T., and V. Poitout. 2009. GPR40: Good cop, or bad cop? Diabetes 58: 1035–1036.
3. Berger, J., and D.E. Moller. 2002. The mechanisms of action of PPARs. Annual Review of Medicine 53: 409–435.
4. Birch, A., L.K. Buckett, and A.V. Turnbull. 2010. DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Current Opinion in Drug Discovery & Development 13: 489–496.
5. Blonde, L. 2010. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. The American Journal of Medicine 123(3A): S12–S18.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献